London, United Kingdom · Founded 2012 · Privately Held (backing)
Developer of next-generation protein-based therapeutics designed to address unmet needs like inflammatory bowel disease. LabGenius Therapeutics is based in London, United Kingdom and was founded in 2012. Its last reported valuation was $85.9 million in Jul 2025. It has raised $93.4 million.
Last reported valuation
$85.9M
Oct 2026
Priced at
—
Total raised
$93.4M
Last round
—
Cap table — not yet on record
LabGenius Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of LabGenius Therapeutics with a free account
·The complete investor list: 35 names
·Watch LabGenius Therapeutics: the Monday email on marks, rounds and moves
